↓ Skip to main content

Dipeptidyl peptidase‐4 (DPP‐4) inhibitors for type 2 diabetes mellitus

Overview of attention for article published in Cochrane database of systematic reviews, April 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

policy
3 policy sources
twitter
1 X user
facebook
1 Facebook page

Citations

dimensions_citation
271 Dimensions

Readers on

mendeley
468 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Dipeptidyl peptidase‐4 (DPP‐4) inhibitors for type 2 diabetes mellitus
Published in
Cochrane database of systematic reviews, April 2008
DOI 10.1002/14651858.cd006739.pub2
Pubmed ID
Authors

Bernd Richter, Elizabeth Bandeira‐Echtler, Karla Bergerhoff, Christian Lerch

Abstract

In type 2 diabetes mellitus there is a progressive loss of beta-cell function. One new approach yielding promising results is the use of the orally active dipeptidyl peptidase-4 (DPP-4) inhibitors like sitagliptin and vildagliptin.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 468 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 5 1%
Germany 1 <1%
Singapore 1 <1%
Spain 1 <1%
Japan 1 <1%
United States 1 <1%
Unknown 458 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 85 18%
Student > Bachelor 53 11%
Researcher 45 10%
Student > Ph. D. Student 45 10%
Student > Postgraduate 30 6%
Other 85 18%
Unknown 125 27%
Readers by discipline Count As %
Medicine and Dentistry 185 40%
Nursing and Health Professions 31 7%
Pharmacology, Toxicology and Pharmaceutical Science 30 6%
Agricultural and Biological Sciences 19 4%
Biochemistry, Genetics and Molecular Biology 15 3%
Other 49 10%
Unknown 139 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 March 2021.
All research outputs
#3,577,420
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#6,116
of 11,499 outputs
Outputs of similar age
#10,862
of 92,972 outputs
Outputs of similar age from Cochrane database of systematic reviews
#21
of 54 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 92,972 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 54 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.